User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Identification of operationally tolerant liver recipients among patients receiving maintenance immunosuppressive therapy.

  1. Weaver Casey T., Harrington Laurie E., Mangan Paul R., Gavrieli Maya, Murphy Kenneth M., Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties, 10.1016/j.immuni.2006.06.002
  2. Andrade Cristiano Feijo, Waddell Thomas K., Keshavjee Shaf, Liu Mingyao, Innate Immunity and Organ Transplantation: The Potential Role of Toll-like Receptors, 10.1111/j.1600-6143.2005.00829.x
  3. Trinchieri Giorgio, Interleukin-12 and the regulation of innate resistance and adaptive immunity, 10.1038/nri1001
  4. Gerosa F., Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10, 10.1084/jem.183.6.2559
  5. Chan S. H., Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers, 10.1084/jem.173.4.869
  6. Metzger Dennis W., McNutt Renee M., Collins John T., Buchanan J. Matthew, Van Cleave Victor H., Dunnick Wesley A., Interleukin-12 acts as an adjuvant for humoral immunity through interferon-γ-dependent and -independent mechanisms, 10.1002/eji.1830270820
  7. Oppmann Birgit, Lesley Robin, Blom Bianca, Timans Jackie C, Xu Yuming, Hunte Brisdell, Vega Felix, Yu Nancy, Wang Jing, Singh Komal, Zonin Francesca, Vaisberg Elena, Churakova Tatyana, Liu Man-ru, Gorman Daniel, Wagner Janet, Zurawski Sandra, Liu Yong-Jun, Abrams John S, Moore Kevin W, Rennick Donna, de Waal-Malefyt Rene, Hannum Charles, Bazan J.Fernando, Kastelein Robert A, Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12, 10.1016/s1074-7613(00)00070-4
  8. Vanden Eijnden Serge, Goriely Stanislas, De Wit Dominique, Willems Fabienne, Goldman Michel, IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T?cells in human, 10.1002/eji.200425677
  9. Hunter Christopher A., New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions, 10.1038/nri1648
  10. Wood Kathryn J., Sawitzki Birgit, Interferon γ: a crucial role in the function of induced regulatory T cells in vivo, 10.1016/j.it.2006.02.008
  11. Chen Y., Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis, 10.1172/jci25308
  12. Mangan Paul R., Harrington Laurie E., O'Quinn Darrell B., Helms Whitney S., Bullard Daniel C., Elson Charles O., Hatton Robin D., Wahl Sharon M., Schoeb Trenton R., Weaver Casey T., Transforming growth factor-β induces development of the TH17 lineage, 10.1038/nature04754
  13. Bettelli Estelle, Carrier Yijun, Gao Wenda, Korn Thomas, Strom Terry B., Oukka Mohamed, Weiner Howard L., Kuchroo Vijay K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, 10.1038/nature04753
  14. Chen WanJun, Jin Wenwen, Hardegen Neil, Lei Ke-jian, Li Li, Marinos Nancy, McGrady George, Wahl Sharon M., Conversion of Peripheral CD4+CD25−Naive T Cells to CD4+CD25+Regulatory T Cells by TGF-β Induction of Transcription FactorFoxp3, 10.1084/jem.20030152
  15. Ivanov Ivaylo I., McKenzie Brent S., Zhou Liang, Tadokoro Carlos E., Lepelley Alice, Lafaille Juan J., Cua Daniel J., Littman Dan R., The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells, 10.1016/j.cell.2006.07.035
  16. Kolls Jay K., Lindén Anders, Interleukin-17 Family Members and Inflammation, 10.1016/j.immuni.2004.08.018
  17. Lockhart E., Green A. M., Flynn J. L., IL-17 Production Is Dominated by    T Cells rather than CD4 T Cells during Mycobacterium tuberculosis Infection, 10.4049/jimmunol.177.7.4662
  18. Miura Masayoshi, Fu Xi, Zhang Qi-Wei, Remick Daniel G., Fairchild Robert L., Neutralization of Groα and Macrophage Inflammatory Protein-2 Attenuates Renal Ischemia/Reperfusion Injury, 10.1016/s0002-9440(10)63065-9
  19. Kelly KJ, J Clin Invest, 97, 1056 (1996)
  20. Miura Masayoshi, El-Sawy Tarek, Fairchild Robert L., Neutrophils Mediate Parenchymal Tissue Necrosis and Accelerate the Rejection of Complete Major Histocompatibility Complex-Disparate Cardiac Allografts in the Absence of Interferon-γ, 10.1016/s0002-9440(10)63845-x
  21. Surquin Murielle, Le Moine Alain, Flamand V??ronique, Rombaut Katia, Demoor Fran??ois-Xavier, Salmon Isabelle, Goldman Michel, Abramowicz Daniel, IL-4 Deficiency Prevents Eosinophilic Rejection and Uncovers a Role for Neutrophils in the Rejection of MHC Class II Disparate Skin Grafts : , 10.1097/01.tp.0000176486.01697.3f
  22. Fidler Mary E., Gloor James M., Lager Donna J., Larson Timothy S., Griffin Matthew D., Textor Stephen C., Schwab Thomas R., Prieto Mikel, Nyberg Scott L., Ishitani Michael B., Grande Joseph P., Kay Paul A., Stegall Mark D., Histologic Findings of Antibody-Mediated Rejection in ABO Blood-Group-Incompatible Living-Donor Kidney Transplantation, 10.1046/j.1600-6135.2003.00278.x
  23. McKenzie Brent S., Kastelein Robert A., Cua Daniel J., Understanding the IL-23–IL-17 immune pathway, 10.1016/j.it.2005.10.003
  24. Langowski John L., Zhang Xueqing, Wu Lingling, Mattson Jeanine D., Chen Taiying, Smith Kathy, Basham Beth, McClanahan Terrill, Kastelein Robert A., Oft Martin, IL-23 promotes tumour incidence and growth, 10.1038/nature04808
  25. Mikols Cassandra L., Yan Le, Norris Jin Y., Russell Tonya D., Khalifah Anthony P., Hachem Ramsey R., Chakinala Murali M., Yusen Roger D., Castro Mario, Kuo Elbert, Patterson G. Alexander, Mohanakumar Thalachallour, Trulock Elbert P., Walter Michael J., IL-12 p80 Is an Innate Epithelial Cell Effector That Mediates Chronic Allograft Dysfunction, 10.1164/rccm.200512-1886oc
  26. Lucas S., Ghilardi N., Li J., de Sauvage F. J., IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms, 10.1073/pnas.2536517100
  27. Villarino Alejandro, Hibbert Linda, Lieberman Linda, Wilson Emma, Mak Tak, Yoshida Hiroki, Kastelein Robert A., Saris Christiaan, Hunter Christopher A., The IL-27R (WSX-1) Is Required to Suppress T Cell Hyperactivity during Infection, 10.1016/s1074-7613(03)00300-5
  28. Holscher C., Holscher A., Ruckerl D., Yoshimoto T., Yoshida H., Mak T., Saris C., Ehlers S., The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis, 10.4049/jimmunol.174.6.3534
  29. Artis D., Villarino A., Silverman M., He W., Thornton E. M., Mu S., Summer S., Covey T. M., Huang E., Yoshida H., Koretzky G., Goldschmidt M., Wu G. D., de Sauvage F., Miller H. R. P., Saris C. J. M., Scott P., Hunter C. A., The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity, 10.4049/jimmunol.173.9.5626
  30. Batten Marcel, Li Ji, Yi Sothy, Kljavin Noelyn M, Danilenko Dimitry M, Lucas Sophie, Lee James, de Sauvage Frederic J, Ghilardi Nico, Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells, 10.1038/ni1375
  31. Hibbert Linda, Pflanz Stefan, de Waal Malefyt Rene, Kastelein Robert A., IL-27 and IFN-αSignal via Stat1 and Stat3 and Induce T-Bet and IL-12Rβ2 in Naive T Cells, 10.1089/10799900360708632
  32. Villarino A. V., Stumhofer J. S., Saris C. J. M., Kastelein R. A., de Sauvage F. J., Hunter C. A., IL-27 Limits IL-2 Production during Th1 Differentiation, 10.4049/jimmunol.176.1.237
  33. Wirtz Stefan, Tubbe Ingrid, Galle Peter R., Schild Hans J., Birkenbach Mark, Blumberg Richard S., Neurath Markus F., Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27, 10.1084/jem.20060471
  34. Villarino A. V., Larkin J., Saris C. J. M., Caton A. J., Lucas S., Wong T., de Sauvage F. J., Hunter C. A., Positive and Negative Regulation of the IL-27 Receptor during Lymphoid Cell Activation, 10.4049/jimmunol.174.12.7684
  35. Murphy Craig A., Langrish Claire L., Chen Yi, Blumenschein Wendy, McClanahan Terrill, Kastelein Robert A., Sedgwick Jonathon D., Cua Daniel J., Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation, 10.1084/jem.20030896
  36. Cruz A., Khader S. A., Torrado E., Fraga A., Pearl J. E., Pedrosa J., Cooper A. M., Castro A. G., Cutting Edge: IFN-  Regulates the Induction and Expansion of IL-17-Producing CD4 T Cells during Mycobacterial Infection, 10.4049/jimmunol.177.3.1416
  37. Veldhoen Marc, Stockinger Brigitta, TGFβ1, a ‘Jack of all trades’: the link with pro-inflammatory IL-17-producing T cells, 10.1016/j.it.2006.06.001
  38. Piccotti JR, J Immunol, 157, 1951 (1996)
  39. Verma N, He X.Y, Chen J, Robinson C, Boyd R, Tran G, Hall B.M, Interleukin 12 delays allograft rejection: effect mediated via nitric oxide, 10.1016/s0041-1345(00)02074-1
  40. Dey BR, Blood, 91, 3315 (1998)
  41. Yang YG, J Clin Invest, 102, 2126 (1998)
  42. Kelvin David J., Zhong Robert, Wang Hao, DeVries Mark E., Deng Shaoping, Khandaker Masud H., Pickering J. Geoff, Chow Larry H., Garcia Bertha, 10.1038/75029
  43. Antonysamy M.A, Fanslow W.C, Fu F, Li W, Qian S, Troutt A.B, Thomson A.W, Evidence for a role of IL-17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival, 10.1016/s0041-1345(98)01453-5
  44. Tang Jian-Lin, Subbotin Vladimir M., Antonysamy Mary A., Troutt Anthony B., Rao Abdul S., Thomson Angus W., INTERLEUKIN-17 ANTAGONISM INHIBITS ACUTE BUT NOT CHRONIC VASCULAR REJECTION1 : , 10.1097/00007890-200107270-00035
  45. Van Kooten C, J Am Soc Nephrol, 9, 1526 (1998)
  46. Vanaudenaerde B. M., The role of interleukin-17 during acute rejection after lung transplantation, 10.1183/09031936.06.00019405
  47. Yoshida S., Haque A., Mizobuchi T., Iwata T., Chiyo M., Webb T.J., Baldridge L.A., Heidler K.M., Cummings O.W., Fujisawa T., Blum J.S., Brand D.D., Wilkes D.S., Anti-Type V Collagen Lymphocytes that Express IL-17 and IL-23 Induce Rejection Pathology in Fresh and Well-Healed Lung Transplants : Col(V)-Reactive Lymphocyte-Induced Lung Disease, 10.1111/j.1600-6143.2006.01236.x
  48. Re Fabio, Strominger Jack L., Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells, 10.1074/jbc.m105927200
  49. Schnurr M., Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway, 10.1182/blood-2004-05-1718
  50. Leemans Jaklien C., Stokman Geurt, Claessen Nike, Rouschop Kasper M., Teske Gwendoline J.D., Kirschning Carsten J., Akira Shizuo, van der Poll Tom, Weening Jan J., Florquin Sandrine, Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney, 10.1172/jci22832
  51. Hochrein Hubertus, O'Keeffe Meredith, Luft Thomas, Vandenabeele Stéphane, Grumont Raelene J., Maraskovsky Eugene, Shortman Ken, Interleukin (Il)-4 Is a Major Regulatory Cytokine Governing Bioactive IL-12 Production by Mouse and Human Dendritic Cells, 10.1084/jem.192.6.823
  52. Goriely S., Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation, 10.1182/blood-2005-06-2416
  53. Gautier Grégory, Humbert Martine, Deauvieau Florence, Scuiller Mathieu, Hiscott John, Bates Elizabeth E.M., Trinchieri Giorgio, Caux Christophe, Garrone Pierre, A type I interferon autocrine–paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells, 10.1084/jem.20041964
  54. Goriely S., Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites, 10.1182/blood-2002-09-2851
  55. Goriely Stanislas, Van Lint Carine, Dadkhah Réza, Libin Myriam, De Wit Dominique, Demonté Dominique, Willems Fabienne, Goldman Michel, A Defect in Nucleosome Remodeling PreventsIL-12(p35)Gene Transcription in Neonatal Dendritic Cells, 10.1084/jem.20031272
  56. Cooke KR, J Clin Invest, 102, 1882 (1998)
Bibliographic reference Sanchez-Fueyo, Alberto ; Lerut, Jan ; Martinez-Llordella, Marc ; Puig-Pey, Isabel ; Lozano, Juanjo ; et. al. Identification of operationally tolerant liver recipients among patients receiving maintenance immunosuppressive therapy..Annual American Transplant Congress (San Francisco (Ca), May 05-09, 2007). In: American Journal of Transplantation, Vol. 7, p. 278-278 (2007)
Permanent URL http://hdl.handle.net/2078.1/59852